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Summary: Investigations have been made up.on the distribution of lipoprotein(a) concentrations in cord and capil-
lary blood from newborns and in serum from in-patient children and adults. Full-tenn neonates (n = 123), children
aged l month to 16 years (n = 331) and adults aged between 17 and 88 years (n = 252) of age were included in
the study.
Lipoprotein(a) was determined using an immunoluminometric assay and a single lot of reagents. The assay had an
effective measuring ränge of 1—800 mg/1.
Lipoprotein(a) could be measured either in cord or capillary blood in the majority of cases. Problems arose in
isolated cases, in each of which there was a large concentration difference in lipoprotein(a) between mother and
child. The correlation data was: r = 0.897, n = 37, log (capillary blood) = 0.874 log (cord blood) + 0.165. The
median lipoprotein(ä) concentrations in cord and capillary blood were 13.9 and 10.2 mg/1 respectively.
Mediän lipoprotein(ä) concentrations increased from birth up until the 6th decade (159 mg/1), decreasing to 95 mg/1
düring the 9th decade of life. In mature newborns, the median lipoprotein(a) concentrations correlated with ges-
tational age.
The distribution of Hpoprotein(a) concentrations in serum is skewed throughout life, the ratio mean/median being
2.07 at birth, 2.71 in children and 2.72 in adults. The percentage of children with lipoprotein(a) concentrations
above 250 mg/1 was 23.0 (male) and 23.8 (femäle). The corresppnding figures for adults was 38.2 for males and
28.2 for females respectively. In the group of newborns 27.7 percent had concentrations above 25 mg/1.
There was ho significant difference between median lipoprotein(a) concentrations after delivery in 80 healthy
mothers aged 17-35 years (92.5 mg/1) and 51 age matched in-patients (104 mg/1). Adult males had significantly
higher median serum lipoprotein(a) concentrations than adult females (p < 0.05, males 144 mg/1, females 89 mg/1).
Introduction 10) and in serum or plasma (9, 11), we have to take
Although several studies have been reported on the lipid ac'ount of different ^ncentration ranges and decision
and lipoprotein concentrations of newborns and children levels- rt is to be exPected that »Poprotein(a) levels in
(l -6), relatively few studies have been reported on the wh°k b!°od are approximately half those in seruni or
establishment of reference ranges for lipoprotein(a) in plasma, and that they are related to the haematocrit.
these groups (7—11). Since lipoprotein(a) levels for Contradictory reports on the serum or plasma levels of
newborns have been determined both in blood spots (8, lipoprotein(a) düring pregnancy and postpartum have
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been published (12, 13); the use of different method-
ology may account for the differences found (12). At
presence there is little or no treatment for diminishing
lipoprotein(a) levels in blood (with the exception of the
HELP apheresis) but there is a need for the early recog-
nition of children at risk of developing atherosclerotic
disease due to abnormally high levels of lipoprotein(a).
Even for adults, the recommended upper limits of lipo-
protein(a) (14) have been accepted without sufficient
investigation or statistical analysis.
This study was implemented to study the concentrations
of lipoprotein(a) in newborns, children, adolescents and
adults, using a single method of detection (15). Capillary
and cord blood concentrations of lipoprotein(a) in new-
borns were compared, in order to establish age-linked
reference ranges, and to establish files on newborns with
elevated lipoprotein(a), so that they can be observed
more frequently and be treated s soon s this becomes
possible. As lipoprotein(a) is accepted s an independent
risk factorNfor atherosclerosis, its serum concentration
can be used to assess the general risk for early cardio-
vascular disease (8), together with the other more gener-
ally accepted lipid and lipoprotein analytes such s total
cholesterol, triacylglycerols and LDL-cholesterol (16).
One advantage of the present study is that all results
were obtained using a single lot of reagents, including
Standard material. This is of importance, because there
are no accepted reference materials for lipoprotein(a),
and different methods give rise to different results (15),
so that comparison of results is often difficult.
Materials and Methods
Subjects studied
Newborns (n = 123) in the gynaecological clinic were examined
for lipoprotein(a) levels using cord blood samples, and where poss-
ible, capillary blood. As the determination of lipoprotein(a) re-
quired only ΙΟ μΙ serum, no problems were encountered. At the
same time, the lipoprotein(a) concentration of the mother was also
measured in serum. If the father was present at the birth, he was
asked whether he would allow blood to be taken for lipo-
protein(a) determination.
In addition, lipoprotein(a) was determined in serum from 331 in-
patient children from the paediatric wards, using samples taken for
routine laboratory tests. None of the children had been admitted
because of a known lipid disorder.
Lipoprotein(a) concentrations were also measured in the serum of
252 non-selected patients from all wards of the Hospital to cover
the age r nge 17-88 years.
Methods of analysis
Lipoprotein(a) was determined using an immunoluminonietric as-
say s already described and published in this Journal (15). As the
samples must be diluted 1 : 1 0 before assay, using a sample size <
of 10 μΐ, the method was suitable for samples from neonates arid
children.
In certain selectcd cases with elevated lipoprotein(a), serum was
subjected to lipid electrophoresis and analysed for triacylglycerols
and cholesterol. Resialts frorn these cases are not presented here.
Statistics
As it is known that lipoprotein(a) is npt normally distributed, non-
parametric tests were used. The mediari was used s the point of
ceutral tendency, the dispersion being given in tefms of relevant
percentiles. Correlations were made using the Spearman rank cor^
relation procedure.
Results
Newborns
Although 123 newborns were included in the study, it
was not possible to obtain cord blood and capillary
blood from each baby, so that only 37 newborns could
be included in this group.
Figure l shows the lipoprotein(a) concentrations in cord
blood plotted against those in capillary blood. As can be
seen, the correlation was good, with several exceptions,
where the cord blood concentration lay between the ma-
ternal and newbora value. The most extreme cases were:
maternal serum 27.6 mg/1, cord blood 103 mg/1, new-
born serum 267 mg/1 and maternal serum 150 mg/l, cord
blood 68.5 mg/1, newborn serum 26.7 mg/1. Combi-
nations such s: maternal serum 1400 mg/1, newborn
serum 14.9 mg/l* i.e. mother high, baby low, were not
uncommon. These values are given to show that the
measured lipoprotein(a) concentration of cord blood is
not always a reliable index of the serum concentrations.
Whenever the concentrations in cord and capillary blood
were discrepant, there was also a large difference be-
tween maternal and offspring lipoprotein(a) levels.
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Fig. l Comparison of lipoprotein(a) concentrations in cord blood
and capillary blood in 37 newbonis. The logarithmic scale was
chosen because the data show a non^Gaussian distribution. The
correlation -coefflcient r = Ό.897; the siope of the regressive line
is: log y = 0.874 (log x) + 0.165.,;
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The median value of the lipoprotein(a) concentrations in
newborns lay well below those found in children older
than 6 months, and in adülts. There was a slight, but
insignificant correlation between lipoprotein(a) concen-
trations at birth and the gestational age, more prema-
turely born babies having lower values on average, äs
seen in figure 2.
Figure 3a shows the distribution of lipoprotein(a) values
in the cord blood of newborns. The median value for
lipoprotein(a) in cord blood was 13.9 mg/1 (ränge
< l -354 mg/1) and in capillary blood 10.2 mg/1 (ränge
< 1—336 mg/1). The values were logarithmically dis-
tributed. In one case, where the mother had a lipo-
protein(a) value of 1150 mg/1, the lipoprotein(a) values
in the baby rose from 125 mg/1 at birth to 169, 264 and
344 mg/1 on days 2, 6 and 9 postpartum. During the
study, two women gave birth to heterozygotic twins, in
each case a boy and a girl. In the one case, the lipo-
protein(a) levels were 3.2 and 3.4 mg/1. The other twins
presented with metabolic problems and were admitted
to hospital at 6 months. The lipoprotein(a) levels were
found to be 684 and 712 mg/1. This demonstrates the
non sex-linked codominant inheritance of lipoprotein(a)
attributes (17, 18).
Children and adolescents (age l month to 16
j years)
)i Figure 2 shows the distribution of median lipoprotein(a)
!» concentrations in serum with age. It is clear that al-
though lipoprotein(a) levels are genetically codomi-
nantly determined, the peak values in serum do not ap-
pear to be reached before the end of the sixth decade of
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Fig. 2 Distribution .of median lipoprotein(a) values in 706 per-
sons from birth up until the 88th year of life. The abscissa is di-
vided into two portions, the left section shows the pregnancy week
in which the child was born, the right section the age groups of
the children, adolescents and aduits.
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life, the median values sinking thereafter. Figure 3b
shows the individual values from 331 children sorted
according to age. Both parents of one child (age 6 years,
with lipoprotein(a) concentrations above 2.3 g/l) had el-
evated levels (mother 945 mg/1, father 1345 mg/1), thus
further supporting the codominant (double-dose) inherit-
ance.
It was surprising how many children in the first year of
life presented with highly elevated lipoprotein(a) con-
centrations, levels of above l g/l being found. The scat-
ter of results is reflected in tables l and 2, and figure
3b. This is applicable to all age groups.
Adülts
Although the results in figure 2 are from non-selected
hospitalised patients, a comparison was made with the
women who were only in hospital to give birth. The
comparison between hospitalised patients of both sexes
between 17 and 35 years and mothers of the same age
can be seen in table 1. Figure 3c shows the individual
results from 252 adülts.
Tabular and graphical data for all groups
Table l summarises the distribution of lipoprotein(a)
concentrations for each age group, in terms of the ränge
and relevant percentiles. Where sufficient data are avail-
able, the groups have also been analysed according to
sex. There was no statistically significant difference in
lipoprotein(a) concentrations between the sexes in new-
borns and children up to 16 years of age. In the adult
group (17—88 years) the median lipoprotein(a) concen-
trations were significantly higher in males (p < 0.05).
Table 2 shows the skewed distribution of the data for
each group and the proportion of subjects in each group
with lipoprotein(a) values above defined limits. Only
relevant values have been included.
Figures 3a—3c show the individual values of all subjects
included in the study. The median values of the data
from figures 3a—3c are shown in figure 2.
Discussion
The aim of the study was to try to establish reference
•ranges for lipoprotein(a) for newbonis and children.
From the results obtained, it can be stated that lipo-
protein(a) reference ränge values can be defined for
newborns, infants up to 6 months and children from 6
months to 16 years. The data presented here would sup-
port the use of an age-dependent recommended upper
limit for lipoprotein(a) concentrations in serum. From
the data in table 2, suggested warning limits are above
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Fig. 3a Scatter of results from the 123 newborns in serum ob-
tained from cord blood. The median values of these results from
the left part of figure 2. The abscissa shows the pregnancy week
in which the child was bom, the ordinate the respective lipppro^·
tein(a) concentrations. The ordinate is logarithmic.
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Fig. 3b Scatter of results from the 331 children. The abscissa
shows the age of the children. Values under l year are entered äs
decimal age, above l year äs integral age. The ordinate is äs in
figure 3a. The median values of the grouped data form the middle
part of figure 2.
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Fig. 3c Scatter of results in the 252 adults. The abscissa shows tion. The median values of the grouped data are shown in the right
integral age, the ordinate the individual lipoprotein(a) concentra- hand part of figure 2. » j;
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Tab. 1 Distribution of lipoprotein(a) values in diffcrcnt age groups.
Group
Newborns
Male
Female
All
Children 0.1 -16 a
Male
Female
All
Adults 17- 88 a
Male
Female
All
Mothers 17-35 a
Others 17-35 a
Percentiles (mg/1)
0.5
*
*
<1
1.6
3.7
1.6
3.5
5.0
3.5
4.1
*
2.5
<l
1.0
1.0
6.1
7.9
7.4
6.5
7.2
6.8
5.8
9.4
16
4.1
3.8
4.0
23.3
14.9
19.5
28.5
26.4
27.0
18.5
19.6
50
13.1
14.2
13.9
69,2
67.8
69.1
144
89.0
115
92.5
104
84
55.6
55.0
55.4
382
360
368
505
469
492
502
423
97.5
255
122
204
1000
1056
1040
1215
1236
1220
1170
1300
99.5
*
*
286
1200
1340
1340
2688
1442
2125
1390
*
Range
<l-339
<1-I02
<l-339
1.0-2455
5.0-1350
1.0-2455
3.5-2800
4.1-1487
3.5-2800
4.1-1400
7.8-2576
The groups comprised 123 newboms, 331 children, 252 adults, 80
mothers and 51 age-matched others. The asterisks denote that the
groups were too small for these values to have any statistical mean-
ing. There was no significant difference between the sexes, except
for the adults, where males had higher values than females
(p < 0.05).
Tab. 2 Distribution of lipoprotein(a) values in the diiferent
groups.
Male
Female
All
Lipoprotein(a)
(mg/1)
> 25
> 50
> 75
>100
>150
>200
>250
>300
Relationship
Newborns
2.36
1.84
2.07
Mean/median
Children
2.61
2.90
2.71
Adults
2.14
2.35
2.72
Percentage of values
27.7
17.7
8.5
6.8
5.3
3.0
1.5
0.75
31.1/27.5*
26.7/25.0
23.0/23.8
20.0/17.5
44.5/33.1
38.2/28.2
27.2/27.5
* The separated values in the lower part of the table are male/fe-
male.
25 mg/1 for newborns in cord blood or serum, above 150
rng/1 for children, above 200 mg/1 adolescents and above
300 mg/1 for adults when the 75th pereentile value is
taken äs in the Framingham second generation study
(19). A sliding scale woüld be naore applicable in terms
of the results in figure 2* äs the median values increase
continuously from birth to the end of the sixth deeade
of life. These values can only be taken äs a guide, äs the
number of observations is too small for setting limits.
The results are interesting inasmuch äs they show that
high lipoprotein(a) concentrations are observable within
the first months of life. Of the children admitted to hos-
pital within the first year of life, 20% (10/50) showed
lipoprotein(a) values above 200 mg/1. Lipoprotein(a)
levels appear to reach maximal levels at the end of the
sixth deeade of life, although a two-fold rise in lipo-
protein(a) values during the first 8 days after birth was
seen in 9/20 newborns, whose blood was taken for other
tests. The general claim that lipoprotein(a) levels in-
crease over the first 8 days of life (9) due to the matu-
ration of lipoprotein(a) gene expression within this time
(8) is not supported by the present study. The claim that
lipoprotein(a) concentrations at 8 months were similar
to those seen in adults (8, 9) could not be confirmed in
the present study. In the limited number of children stud-
ied over the first 9 days of life the only observation
made was that in 9/10 children with a cord serum lipo-
protein(a) value over 25 mg/1, this value rose over the
observation period by a factor of 2—3, the lOth child
having a value which remained constant around 27 g/l.
No such incresae was observed in 10 children with lipo-
protein(a) values at birth under 20 mg/1. These findings
indicate that newborns with a lipoprotein(a) concen-
tration above 25 mg/I should be checked again at around
6 months of age.
For ethical reasons, it was not possible to include a
group of non-hospitälised healthy children for compari-
son. The fact that the children were admitted to the hos-
pital without known lipid disorders would support the
Eur. J. Clin. Chem. Clh% Bipchem. / Vol. 32.1994/No. 5
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theory that the results presented here reflect the Situation
in the general population. This is borne out further by
comparison of the values of the mothers with those from
both men and women of the same age, who were hospi-
talised.
It has been reported that apolipoprotein B synthesis at
birth is only 30% of that found in adults, and the syn-
thesis of this apolipoprotein reaches adult levels after 7
days (9). The low concentrations of lipoprotein(a) re-
ported here are not, however, due to a low synthesis of
apolipoprotein(a). The assay used in the present study
employed two antibodies directed against apolipo-
protein(a), i.e. the sandwich partner was not directed
against apolipoprotein B, although such an assay has
been published from this laboratory (15). Other authors
(9) have shown that the synthesis of apolipoprotein(a)
first reaches maturity after about 180 days. The present
results show that the ränge of values seen at about 6
months is-similar to that in adults, although the median
value is lower (flg. 3a).
An interesting observation was that the median lipo-
protein(a) values in males decreased after the com-
pletion of the 6th decade of life. This is not due to de-
creased synthesis, but due to the death of those with
high lipoprotein(a) from atherosclerotic and cardiovas-
cular disease. All patients older than 70 and with grossly
elevated lipoprotein(a) (over l g/l) were women. The
spread of results, äs seen in table l, shows that the con-
centrations of lipoprotein(a), äs well äs being log-nor-
mally distributed, have a sinailar distribution (mean/me-
dian) throughout life.
The logarithmic distribution of results can be seen
clearly from all figures, yet many research groups still
give concentrations in terms of mean and Standard devi-
ation, although this has been rightly criticised äs reduc-
ing the value of such publications (20).
The most striking findings were that the lipoprotein(a)
median concentrations follow the "stress-curve" of life,
peaking exactly during the 15 years where the most
myocardial infarction cases occur. One must postulate
that although lipoprotein(a) disposition is genetieally de-
termined, lipoprotein(a), like the other lipid "risk fac-
tors" is affected by the stress of daily life. This point
must be taken into account wheii advising the parents of
children and adolescents to adopt a life style where
stress is kept to a minimum. A dietary education pro*
gramme for children with elevated cholesterol levels has
already been published and is based on both dietary, äs
well äs "hands-on" therapy (21).
Current concepts must be changed äs new facts concern-
ing lipoprotein(a) come to light, especially if the hypoth-
esis that the size of the lipoprotein(a) molecule influ-
ences its atherosclerotic effects proves to be correct.
Finally, it must be stated that the results here are from
deflned groups of subjects of Caucasian origin, and in
the light of other studies on lipid analytes (22—24) may
not be transferable to other ethnic groups ör to mixed
populations, although studies on black and white öew-
borns (11) have shown no diiference in lipoprotein(a)
concentrations at birth between the two races.
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